Annovis Bio, Inc. (ANVS) Return on equity 2020–2025
Annovis Bio, Inc. (ANVS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-171.2%FY2025 · since FY2020: -72.4% → -171.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -171.2% | +93.0 pp |
| FY2024 | -264.2% | — |
| FY2022 | -89.4% | -56.9 pp |
| FY2021 | -32.6% | +39.9 pp |
| FY2020 | -72.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More ANVS financial trends
ANVS RevenueANVS Net incomeANVS Net marginANVS Gross profitANVS Gross marginANVS Operating incomeANVS Operating marginANVS Operating cash flowANVS Free cash flowANVS Capital expendituresANVS Stock buybacksANVS Dividends paidANVS Total assetsANVS Total liabilitiesANVS Shareholders’ equityANVS overview →